Search

everythinglearnresearchcommunity

for

Search:↓

Thicker hair grows faster; hair loss patients have slower growth.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Early skin biopsy helps diagnose and manage severe skin conditions in babies.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Wharton's jelly secretomes are best for promoting blood vessel growth.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

The EFSUMB created basic guidelines for using ultrasound in skin-related medical practice.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Some cancer treatments can cause permanent hair loss.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Stem cells from umbilical cord blood may prevent hair loss caused by certain medications.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Using a blow dryer in a certain way can cause localized hair damage with bubble formation inside the hair.

Umbilical cord cells may help delay skin aging.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.